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Abstract
Background: Bacillus anthracis, Francisella tularensis, and Yersinia pestis are bacterial pathogens that can cause anthrax,
lethal acute pneumonic disease, and bubonic plague, respectively, and are listed as NIAID Category A priority pathogens for
possible use as biological weapons. However, the interactions between human proteins and proteins in these bacteria
remain poorly characterized leading to an incomplete understanding of their pathogenesis and mechanisms of immune
evasion.
Methodology: In this study, we used a high-throughput yeast two-hybrid assay to identify physical interactions between
human proteins and proteins from each of these three pathogens. From more than 250,000 screens performed, we
identified 3,073 human-B. anthracis, 1,383 human-F. tularensis, and 4,059 human-Y. pestis protein-protein interactions
including interactions involving 304 B. anthracis,5 2F. tularensis, and 330 Y. pestis proteins that are uncharacterized.
Computational analysis revealed that pathogen proteins preferentially interact with human proteins that are hubs and
bottlenecks in the human PPI network. In addition, we computed modules of human-pathogen PPIs that are conserved
amongst the three networks. Functionally, such conserved modules reveal commonalities between how the different
pathogens interact with crucial host pathways involved in inflammation and immunity.
Significance: These data constitute the first extensive protein interaction networks constructed for bacterial pathogens and
their human hosts. This study provides novel insights into host-pathogen interactions.
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Introduction
Bacillus anthracis, Francisella tularensis and Yersinia pestis are known
to cause pathogenesis, in part, by evading or suppressing immune
responses. For instance, it is well recognized that anthrax lethal
toxin (LT) is a key player in the B. anthracis pathogenic mechanism
that induces macrophage apoptosis [1] and cleavage of MAPK at
specific recognition sites [2]. Y. pestis suppresses local inflammation
and impairs macrophage phagocytic activity through a complex
type III secretion system (T3SS) and its associated protein LcrV
[3]. F. tularensis either fails to induce an immune response or causes
immune suppression by inducing transforming growth factor
(TGF-b) [4]. Both Y. pestis and F. tularensis are Gram-negative
bacteria that synthesize lipopolysaccharide (LPS) with poor Toll-
like receptor 4 (TLR4)-stimulating activity, although F. tularensis
can signal via TLR2 [5]. Thus, all three pathogens share similar
mechanisms of pathogenesis that involve modulation of immune
responses. Traditional microbiology and immunology approaches
have characterized only a few pathogenic proteins for each
microbe, resulting in a limited understanding of pathogenicity and
evasion mechanisms.
In contrast to investigating either the host or the pathogen,
focusing on interactions between host and pathogen proteins may
uncover hidden associations that have not been detected by
traditional methods. To uncover host-pathogen protein interac-
tions on a genome-wide scale for these three immune-evading
systems and to define a target set of proteins for understanding
mechanisms of pathogenicity, we designed a high-throughput
yeast two-hybrid assay aimed at characterizing protein-protein
interactions (PPIs) between human and bacterial proteins. We
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activation domain libraries containing human proteins in a
haploid Mata strain of Saccharomyces cerevisiae. We tested for
activation of the two-hybrid reporter genes using a similar protocol
that was previously used for identifying interactions between
proteins in Plasmodium falciparum [6]. We then sequenced positive
colonies to identify interacting partners (see Figure 1A). In total,
we performed more than 250,000 screens across the three
pathogens. We obtained 3,073 PPIs between 1,748 human
proteins and 943 B. anthracis proteins, 1,383 PPIs between 999
human proteins and 349 F. tularensis proteins, and 4,059 PPIs
between 2,108 human proteins and 1,218 Y. pestis proteins. We
used an independent computational analysis to study the network
properties (degree and centrality) of the human proteins that
interact with pathogen proteins in our dataset. Additionally, we
used a graph-alignment algorithm to identify conserved subsets of
human-pathogen PPIs found across multiple networks.
These data constitute the first extensive protein interaction
networks constructed for bacterial pathogens and their human
hosts. Typically, data detailing host-pathogen interactions is
ascertained from small-scaled experiments that are designed to
target specific proteins, complexes, or pathways of interest. This is
evident from the number of interactions between host and
bacterial pathogens currently available in seven public resources
[7,8,9,10,11,12,13]. For example, these databases only contain
one human-B. anthracis interaction, no human-F. tularensis interac-
tions, and seven human-Y. pestis interactions.
Results and Discussion
In total we identified 3,911, 1,942, and 5,157 PPIs for the
human-B. anthracis, human-F. tularensis, and human-Y. pestis
networks respectively. We filtered this set of PPIs by removing
human proteins that interact with large number of pathogen
proteins identified by multiple screens with other pathogens
(unpublished data), reasoning that such interactions are likely to be
false positives. This step yielded a final set of 3,073, 1,383, and
4,059 PPIs for the human-B. anthracis, human-F. tularensis, and
human-Y. pestis networks respectively (see Table 1). We found that
888 human-B. anthracis, 167 human-F. tularensis, and 2,205 human-
Y. pestis PPIs contain pathogen proteins that are labeled as
‘‘putative’’, ‘‘hypothetical’’, or ‘‘uncharacterized’’. See Figure 1B
for a comparison of the sets of human proteins found to interact
with each of these pathogens.
Bacterial pathogens have evolved to interact with human
hubs and bottlenecks
Several recent studies [14,15] have suggested that viral proteins
have evolved to preferentially interact with protein hubs (proteins
with many interacting partners) and bottlenecks (proteins that lie
in shortest paths between many pairs of proteins) in the human
PPI network. We hypothesized that bacterial proteins interact with
human proteins with high degree and centrality, since pathogens
may have evolved to control and disrupt essential complexes and
pathways governing the host response. Our analysis supports this
hypothesis. More specifically, Figure 2(a) displays a log-log plot of
the degree distributions of six sets of proteins in a human PPI
network collated from multiple databases [7,8,9,10,11,12,13].
These plots show that across almost the entire range of degrees,
human proteins interacting with bacterial pathogens tend to have
higher degree than proteins that do not interact with any
bacterium. The betweenness centrality results display the same
trend (see Figure 2(b)). We used Gene Set Enrichment Analysis
(GSEA) [16] to test whether the gaps we observe in Figure 2
between the curve for all non-pathogen interactors and the other
curves are statistically significant. GSEA yields p-values less than
10
26 for both degree and centrality for all sets, supporting the
conclusions we draw from Figure 2. To address the possibility that
the observed patterns may be artifacts of experimental biases or
errors in the human PPI network, we followed an earlier approach
for viral-human PPIs [15]: we repeated the GSEA analyses using
two subsets of the human PPI network: (i) interactions detected by
small-scale experiments and (ii) interactions observed by large-
scale studies. We obtained statistically-significant results in both
cases (see Table 2).
Bacterial pathogens target host defense pathways
Since conserved interaction networks between bacterial proteins
and the host may be indicative of putative novel targets for broad-
based immunotherapeutic development, we asked if human
proteins interacting with multiple pathogens may be involved in
functions related to host response. Since manipulation of immune
responses in the host has been linked to infection by all three
pathogens [17,18,19], we identified 60 human immune modula-
tion proteins using annotations from the Gene Ontology [20] and
their bacterial interactors (see Figure 3). While many of the
proteins in the human-respiratory pathogen interaction map play
a role in apoptosis, they are also important effectors of immune
response signaling. Thus, the double role in apoptosis and immune
response regulation should be considered when interpreting these
results. This network includes interactions among sets of bacterial
and human proteins involved in innate immunity (i.e., TLR4 and
TLR7), inflammation (IL-8RB, NF-kB and Bcl-6), recruitment of
inflammatory cells, regulatory function, maturation and activation
of T cells (i.e., CXCR4, STAT3, NOTCH2, and LCK). For
example, LCK is a tyrosine kinase expressed in T cells associated
with the cytoplasmic tail of CD4 and CD8 co-receptors.
Functionally, LCK is a crucial regulator of T cell activation
[21]. Of note, LCK interacts with proteins from all three
pathogens, suggesting that these bacteria may have developed
conserved mechanisms of impairing effector T cell responses by
targeting and possibly disrupting LCK signaling, which is required
for inducing acquired immune responses and immune-mediated
protection against infectious diseases.
CXC-chemokine receptor 4 (CXCR4) is the major coreceptor
for human immunodeficiency virus in CD4
+ T cells and a
promising new target for developing anti-HIV drugs [22]. We find
that CXCR4 interacts with the yscP protein, a known virulence
factor from Y. pestis and a secreted component of the Yop secretion
system [23]. The natural ligand for CXCR4 is CXCL12 or SDF1
(stromal cell-derived factor-1) – a chemokine involved in the
recruitment of down-modulatory FOXP3
+ regulatory T cells
(Treg) into inflamed tissues [24]. In addition, STAT3 is required
for expression of FOXP3 in Treg [25]. Our data demonstrate that
STAT3 interacts with the Y1119 protein of Y. pestis. In turn, we
show that TGF-b1, a down-modulatory cytokine produced by
Treg, interacts both with Y. pestis and F. tularensis proteins. The
Schu4 strain of F. tularensis has been shown to suppress
inflammation in infected mice, and this inhibition has been
attributed to induction of TGF-b, another member of the
apoptosis PPI network [4]. Similar patterns have been observed
in B. anthracis and Y. pestis [26,27]. The existence of a putative
mechanism of down-regulating immune responses by targeting
regulatory pathways merits closer attention.
Comparative analysis of human-pathogen networks
Encouraged by the evidence in our data suggesting that all three
pathogens target proteins involved in host response to infection,
Human-Bacterial PPI Networks
PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12089Figure 1. Overview of experimental workflow. A) Overview of analysis pipeline used in this study. B) Venn diagram displaying the number of
human proteins interacting with each of the three pathogens in this study.
doi:10.1371/journal.pone.0012089.g001
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the three host-pathogen PPI networks. In preparation for
computing conserved modules of host-pathogen PPIs, we used
Inparanoid [28] to identify orthologous proteins and OrthoMCL
[29] to identify paralogous proteins. From the Inparanoid
algorithm we identify a total of 686, 1,179, and 834 pairs of
orthologous clusters for the B. anthracis-F. tularensis, B. anthracis-Y.
pestis, and F. tularensis-Y. pestis comparisons respectively. We find
that 181,505, and 184 of these clusters from the respective
comparisons contain more than one protein from either organism.
Of these, 93,210, and 129 clusters contain at least one pathogen
protein from both organisms that was observed to interact with a
human protein in our dataset (see Table 3). We find 1,900 clusters
of human proteins from the OrthoMCL analysis.
First, we performed simple intersections of the detected host-
pathogen PPIs. We looked for interologs [30] i.e., a pair of human-
bacterial PPIs where the bacterial proteins are orthologous and the
human proteins are related. More specifically, we searched for
three types of configurations:
i. a triple of proteins a, b, and c, where a is a human protein that
interacts with a protein b in one of the three bacteria and with
a protein c in another bacterium in our data and b and c are
orthologs of each other,
ii. a quadruple of proteins a, b, c, and d, where a, b, and c are as
defined before, d is a human protein, a and d interact with
each other physically in the human PPI network, a interacts
with b in our data and d interacts with c in our data, and
iii. a quadruple of proteins a, b, c, and d, where a, b, and c are as
defined before, d is a human protein, a and d are paralogs, a
interacts with b in our data and d interacts with c in our data.
As can be seen from Table 4, our interaction data contains a
very small number of interologs.
Since, simple intersections of host-pathogen PPIs did not yield
substantial information on conserved PPI networks, we applied
four published algorithms for identifying conserved protein
interaction modules (CPIMs) amongst the three human-pathogen
networks and homology relationships previously identified:
Graemlin [31], Match-and-Split [32], NetworkBLAST [33], and
GraphHopper [34]. These methods were originally designed to
identify conserved modules between intra-species PPI networks.
Graemlin requires the user to provide the topology of expected
conserved modules as positive examples. Thus, Graemlin was not
directly applicable to our scenario since there are no such
examples available for these systems. Using the Match-and-Split
algorithm we were not able to identify any CPIMs in any of the
comparisons. In the case of NetworkBLAST, where there are a
number of user parameters that can be adjusted, e.g., complex
density and false negative rates, we tried different combinations of
values. For the parameter complex density, we varied the input
value from 0.50 to 0.95, adjusting values by 0.05 for each test. We
performed the same procedure for testing the range of 0 to 0.80 for
the FN ratios. Varying the parameters for the NetworkBLAST
algorithm had no effect on the identified CPIMs in our case,
yielding three CPIMs for the B. anthracis-F. tularensis comparison,
ten CPIMs for the B. anthracis-Y. pestis comparison, and two CPIMs
for the F. tularensis-Y. pestis comparison. Using the GraphHopper
[34] algorithm we were able to identify many more significant
CPIMs. In total we identified 39 CPIMs for the B. anthracis-F.
tularensis comparison, 64 for the B. anthracis-Y. pestis comparison,
and 41 for the F. tularensis-Y. pestis comparison. Table 5 displays the
number of identified CPIMs for each of the algorithms. We discuss
two sets of CPIMs computed by GraphHooper below related
antigen presentation and immune modulation.
Table 1. Summary of human-pathogen interactions.
Organsim # PPIs # PPIs* # H. sapiens # pathogen # pathogen
proteins proteins proteins
*
B. anthracis 3,073 888 1,748 943 285
F. tularensis 1,383 167 999 349 66
Y. pestis 4,059 2,025 2,108 1,218 630
Counts in columns marked with an ‘‘*’’ correspond to pathogen proteins
labeled as ‘‘putative’’, ‘‘uncharacterized’’, or ‘‘hypothetical’’.
doi:10.1371/journal.pone.0012089.t001
AB
Figure 2. Network properties of interacting proteins. Cumulative log-log plots of (A) node centralities and (B) degrees for six subsets of nodes
in the whole human protein-protein interaction network: the red curve is for the set of proteins in the human PPI network that do not interact with
any pathogen in our dataset; the green line is for the set interacting with B. anthracis; the dark blue line is the for set interacting with F. tularensis; the
purple line is for the set interacting with Y. pestis; the light blue line is for the set interacting with at least two pathogens; and the orange line is for
the set interacting with all three pathogens. The fraction of proteins at a particular value of degree or centrality is the number of proteins having that
value or greater divided by the number of proteins in the set. (Counts in parentheses represent the number of proteins in each set.)
doi:10.1371/journal.pone.0012089.g002
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responsible for presenting antigens to T cells. Antigen processing
and presentation is crucial for activating T cells and mounting
protective immune responses. Our analysis captures CPIMs
containing human proteins enriched in both antigen processing
and presentation functions (Figure 4(a) shows the network for the
B. anthracis – Y. pestis system). We find an interaction between the
human HLA-B protein and the B. anthracis pagA protein. HLA-B is
an MHC class I protein responsible for presenting antigen
fragments to CD8
+ T-cells. The pathogen pagA protein, along
with the lethal factor and oedema factor, is one of three proteins
composing the anthrax toxin. Functionally, the pagA protein
facilitates the translocation of enzymatic toxins across the cell
membrane. Also interacting with HLA-B is the Y. pestis yscP
protein, which is part of the Yersinia outer-membrane protein
(YOP) secretion system. Members of the YOP family have been
shown to interact with MHC I proteins in the closely related
pathogen, Yersinia enterocolitica [35]. Other members of the MHC
class I family in these CPIMs include HLA-A, HLA-C, and HLA-
E. We also identify a number of interactions for human proteins
belonging to MHC class II (e.g., HLA-DRA, HLA-DPB1, HLA-
DQB1, and HLA-DMB), which are responsible for presenting
antigens to CD4
+ T cells. These MHC class II proteins interact
with various pathogen proteins including pathogen membrane
proteins and yet uncharacterized proteins.
The CPIMs in Figure 4(b) represent pathogen interactions with
human proteins involved in immune response pathways for the B.
anthracis – Y. pestis system. Each CPIM includes NF-kB, which is a
transcription factor found at the crossroads of numerous immune
and inflammatory pathways leading to the induction of innate and
acquired immune responses. NF-kB is found downstream of the
Toll family of receptors, which participate in signaling in response
to infection. Pathogens have evolved to disrupt this critical process
and thereby evade the host response. Inhibition of the NF-kB
pathway impairs both the activation and differentiation of T cells
and antigen-presenting cells. In the case of Y. pestis, the inhibition
of the NF-kB pathway is necessary for rapid apoptosis in infected
macrophages [36]. We find several members of the Y. pestis YOP
family, including yscI, yscK, and yopD along with virulence
factors such as the toxin tccC1 and the protein kinase ypkA
interacting with NF-kB. Many of the other pathogen interactors of
NF-kB are labeled as ‘‘uncharacterized’’ proteins. We also observe
interactions between the Y. pestis proteins usg (an aspartate-
semialdehyde dehydro-genase) and tar1 (a methyl-accepting
chemotaxis transmembrane protein) and the human IKK-A
protein. IKK-A phosphorylates inhibitors of NF-kB, leading to
their degradation and resulting in NF-kB activation. We report an
interaction between human NFkB-IA, a NF-kB inhibitor that
binds to NF-kB and traps it in the cytoplasm, and the Y. pestis
protein y3760, a putative multi-drug resistance protein. Upstream
of NF-kB we demonstrate alr1-TLR4 and Y1119-TLR7 interac-
tions. TLR4 and TLR7 are receptors for LPS and viral single-
stranded RNA, respectively. It is well recognized that both Y. pestis
and F. tularensis synthesize LPS with poor TLR4-stimulating
activity. However, these further interactions may render NF-kB
non-functional. Our findings suggest a strong interaction between
bacterial proteins and proteins of the human immune system that
are both crucial for effector activity and conserved.
Materials and Methods
Experimental Methods
We used a random yeast two-hybrid approach to identify
physical interactions between human proteins and pathogen
proteins. See Figure 1 for an overview of the experimental
analytical processes used in this study.
Table 2. GSEA results.
Degree Centrality
Network Group # proteins ES # proteins p-value ES # proteins p-value
in group contributing contributing
B. anthracis 1,269 0.28 834 ,10
26 0.46 1,269 ,10
26
F. tularensis 729 0.28 574 ,10
26 0.45 729 ,10
26
W Y. pestis 1,514 0.28 1,325 ,10
26 0.47 1,514 ,10
26
Multiple 828 0.31 579 ,10
26 0.46 828 ,10
26
All 241 0.32 187 ,10
26 0.45 241 ,10
26
B. anthracis 608 0.39 608 ,10
26 0.60 608 ,10
26
F. tularensis 373 0.38 373 10
26 0.59 373 ,10
26
HT Y. pestis 723 0.39 723 10
26 0.60 723 2610
26
Multiple 421 0.39 421 ,10
26 0.60 421 ,10
26
All 127 0.38 127 ,10
26 0.59 127 2.9610
25
B. anthracis 1,109 0.24 853 ,10
26 0.41 1,109 ,10
26
F. tularensis 637 0.24 500 ,10
26 0.41 637 ,10
26
MC Y. pestis 1,331 0.24 1,153 ,10
26 0.42 1,331 ,10
26
Multiple 733 0.28 596 ,10
26 0.41 733 ,10
26
All 214 0.30 165 ,10
26 0.40 214 ,10
26
Summary of GSEA results for protein degree and betweenness centrality of human proteins for three networks: (W) whole human PPI network, (HT) the human PPI
network generated by only considering high-throughput experiments, and (C) the human PPI network generated by only considering manually curated PPIs. The ‘‘#
proteins in group’’ displays the total number of human proteins with at least one interaction. The ‘‘ES’’ columns display the enrichment score calculated by the GSEA for
degree and for centrality. The column titled ‘‘# proteins contributing’’ displays the number of proteins contributing to the ES score.
doi:10.1371/journal.pone.0012089.t002
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the random two-hybrid process are based on the Saccharomyces
cerevisiae Gal4p DNA-binding domain (amino acids 1 to 147 for
DBDconstructs)andtranscriptionalactivationdomain(amino acids
768 to 881 for activation domain libraries). Both vectors have
elements suitable for growth in both bacterial and yeast cells. Two
Figure 3. Interactions with host innate immune response. Interactions of human proteins involved in the innate immune response. We
divided the human protein into subsets based on whether they induce or prevent apoptosis, or whether they regulate apoptosis. Proteins in the
group labeled ‘‘Non-specific’’ do not have an annotation more specific than ‘‘Apoptosis’’ in the Gene Ontology [20]. For clarity this image shows only
interactions involving virulence factors and uncharacterized pathogen proteins. As a result, some human proteins in the figure may appear to have
no interacting partners.
doi:10.1371/journal.pone.0012089.g003
Table 3. Inparanoid ortholog groups.
System # clusters # clusters # clusters
(.2 proteins) (pathogen
interactors)
B. anthracis-F. tularensis 686 181 834
B. anthracis-Y. pestis 1,179 505 184
F. tularensis-Y. pestis 834 210 129
Summary of ortholog groups identified by Inparanoid [28]. The column marked
‘‘# clusters (.2 proteins)’’ is the number of orthologous clusters that contain
more than a single protein from each organism. The column marked ‘‘# clusters
(pathogen interactors)’’ is the number of orthologous clusters which contain a
pathogen protein from each organism that is known to interact with a human
protein in our dataset.
doi:10.1371/journal.pone.0012089.t003
Table 4. Conserved interactions.
System #ortholog #same #direct #paralogous
pairs protein interaction interactor
pairs pairs pairs
B. anthracis –F. tularensis 60 3 0 2
B. anthracis –Y. pestis 97 5 0 3
F. tularensis –Y. pestis 98 1 0 3
Summary of bacterial interologs. each row is a pair of bacteria, column 1 is the
number orthologous pairs of proteins that both interact with a human protein,
column 2 is number of these pairs that interact with the same protein, column 3
is number of these pairs that interact with human proteins that interact
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in the open reading frame (ORF) selection strategy. The DBD
fusion vector pOBD.109 has a marker for selection of tryptophan
prototrophy (TRP1) and kanamycin resistance. The second DBD is
first cloned into the vector pOBD.111 where ORFs are selected
using MET2. We then PCR amplified all ORFs and clone them
into the fusion vector Super B DBD. The Activation Domain (AD)
fusion vector pGAD.PN2 has selection for leucine prototrophy
(LEU2) and ampicillin resistance (ampR). In both vectors,
expression of the fusion proteins is constitutively driven by the
ADH1 promoter. Both vectors also contain centromeric sequences
that serve to stably maintain the plasmids and keep the copy
number to one or two per cell. For the random two-hybrid
experiments, we used a proprietary DNA-binding domain vector
that permits the selection of inserts containing open reading frames
(pOBD.111). This selection was achieved by inserting a MET2
selectable marker in-frame and downstream of Gal4p DNA-binding
domain and the cloning site. In the absence of selection for an in-
frame open reading frame (ORF), the majority of inserts will be
from non-coding regions or will be out of frame, and therefore of no
utility in a two-hybrid assay. Using this ORF selection strategy,
greater than 80% of the cloned inserts in these vectors contain open
reading frames after nutritional selection. The DNA-binding
domain vectors we used, pOBD.111 and pOBD.109, are slightly
modified to facilitate the cloning of bacterial genomic DNA
fragments that have had linkers added to their ends. The haploid
yeast strain used to express the DNA-binding domain fusions,
PNY200, has the following genotype: MATa trp1-901 leu2-3,112
ura3-52 his3-200 ade2 gal4 gal80. The haploid yeast strain used to
express the activation domain fusions, PJ69-4A1, has the following
genotype: MATa trp1-901 leu2-3,112 ura3-52 his3-200 ade2 gal4
gal80 GAL2-ADE2 LYS2::GAL1-HIS3 met2::GAL7-lacZ. The
two yeast strains are derived from the same parent cell line and
display high mating efficiencies. Both allow for the introduction and
selection of vectors carrying the yeast selectable markers TRP1,
LEU2, and URA3. The activation domain strain contains three
different Gal4p-responsive reporter genes: GAL2-ADE2 and
GAL1-HIS3, which are assayed by selection on yeast synthetic
media lacking either adenine or histidine, respectively, and GAL7-
lacZ, which can be monitored using colorimetric or luminescent
assays for beta-galactosidase activity. The HIS3 reporter exhibits a
low level of background His3p expression that can be counteracted
byuseof3mM3-amino-1,2,4-triazole,acompetitiveinhibitorofthe
His3p protein. These markers are unrelated except for the small
GAL4 binding sites in their promoters. Since it is very unlikely that
all three genes would be spuriously activated if their promoters are
so distinct, the likelihood of false-positives is reduced.
Generation of DNA-binding domain libraries. We cloned
fragments of B. anthracis, F. tularensis, and Y. pestis genomic DNA
into DNA-binding domain vectors pOBD.111 and pOBD.109 to
create libraries for two-hybrid analysis. We obtained the genomic
DNA from the laboratories of Dr. Kenneth Bradley (University of
California, Los Angeles), Dr. Martha Furie (Stony Brook
University), and Dr. James Bliska (Stony Brook University)
respectively. Bacterial genomic DNA insert preparation involves
the mechanical (sonication) and enzymatic (cviJI**) shearing to
produce random fragments of an average size of 500 bp. We
blunted single-stranded overhangs to recover fragments of desired
size. We then ligated purified fragments to linkers and co-
transform them into bacterial cells with an equimolar amount of
linearized vector. We then transformed the entire ligation and
plate onto selection plates for amplification. We pooled colonies
and isolated plasmid DNA for transformation into yeast.
Preparation of DNA-binding domain fusions. In order to
randomly screen each DBD library we plated an aliquot of the
DNA-binding domain library on yeast synthetic media lacking
tryptophan at a density that allows the selection of individual yeast
colonies. After a three to four day incubation, we picked individual
yeast clones into a 96 well plate containing yeast rich media (YPD).
We then incubated the plate at 30u for one to two days to permit
the growth of a sufficient quantity of DNA-binding domain yeast.
Random yeast two-hybrid screens. Our strategy is similar
to one used by LaCount et al. [6] used to identify interactions
between proteins in Plasmodium falciparum.
We generated DNA-binding domain libraries in a haploid
MATa strain and the human spleen activation domain library in a
MATa strain. We mated each haploid yeast culture containing a
single DNA-binding domain fusion to generate diploid yeast cells
that express both the DNA-binding and activation domain fusions.
In contrast to LaCount et al., we used a liquid-format mating
strategy in a 96-well plate (as opposed to mating on filters or agar),
thus allowing for the generation of greater than 500,000 diploids
(and, therefore, protein combinations). We selected two-hybrid
positives on yeast minimal media lacking tryptophan and leucine
(to select for mating events), and lacking histidine and adenine (to
select for activation of the two-hybrid reporter genes).
The goal was to analyze the vast majority of B. anthracis, F.
tularensis, and Y. pestis proteins as DNA-binding domain fusions. The
DNA-binding domain libraries contain fragments sizes selected to
be larger than 300 bp and with the average insert size of 500 bp
(167 amino acids). We chose the 300 bp minimum because many
recognizable protein domains are in this size range; in addition, this
size of fragment works well in yeast two-hybrid assays.
We generated comprehensive protein interaction maps by
performing a ten-fold coverage of the coding capacity of each of
the pathogen genomes. We calculated the number of screens by
dividing the total genomic sequence of the pathogen by the
average fragment size in the DNA-binding domain library
(500 bp) and multiplying by ten (fold coverage).
Analysis of positive screens. We incubated the yeast
selection plates for ten days. We experienced three different
outcomes: 1) Some plates exhibited no growth of yeast colonies
and are discarded without further analysis; 2) Some plates exhibited
growth of a very large number of colonies (from hundreds of yeast
colonies to a lawn of yeast); 3) The remaining plates contained a
modest number of colonies, from one to a few hundred. In the first
scenario where there are no colonies returned, we assumed that
there are no detectable interactors for those protein fragments. In
the second case where a very large number of colonies are found, it
is likely that the DNA-binding domain fusions possess inherent self-
activation ability and were not worthy of further investigation, as
they did not represent protein interaction pairs. After analyzing
many thousands of searches, it is our experience that DNA-binding
Table 5. CPIM results.
Alorithm B. anthracis- B. anthracis- F. tularensis-
F. tularensis Y. pestis Y. pestis
Graemlin N/A N/A N/A
Match-and-Split 0 0 0
NetworkBLAST 3 10 2
GraphHopper 39 64 41




PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e12089domain fusions yielding in excess of 100 colonies per search are
likely self-activators. Typically, our ORF-selected DNA-binding
domain libraries contain two to five percent self-activating baits, in
agreement with the frequencies observed for random fragments of
Escherichia coli and bacteriophage T7.5 [37,38].
We selected colonies for further analysis and transfered them to
fresh media. We amplified both the DNA-binding and activation
domain inserts by PCR and sequenced the resulting products using
dye-primerchemistryoncapillaryinstruments.Weusedtheresulting
sequence information to identify the interacting protein fragments.
Filtering positive interactions. We retained interactions for
positive colonies in which the insert is in the correct orientation,
contains one but no more than two annotated genes, and does not
contain multiple genomic fragments that had been ligated together.
Figure 4. Conserved protein interaction modules. Conserved modules of human-pathogen PPIs involved in (A) antigen binding and processing
and (B) immune response pathways. For clarity these images show only the conserved modules from the comparison of B. anthracis and Y. pestis, and
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Notation. We represented each experimentally derived
human-bacterium protein-protein interaction (PPI) network as a
bipartite graph B=(H, P, I), where H is the set of human proteins,
P is the set of proteins in the bacterium, and I is a set of edges
(interactions), each of which connects one protein in H to a protein
in P. Further, we represented the set of known intra-species
(human) protein-protein interactions as an undirected graph
G=(V, E), where V is the set of nodes (human proteins) and E is
the set of edges (interactions). We now describe in detail the tests
we used to analyze each of the human-pathogen networks.
Analysis of degree in the human PPI network. The degree
of a protein in a graph is the number of interactions in which it
participates. We plotted the degree distributions for six sets of
human proteins: (i) the set of all human proteins not interacting
with a pathogen protein in our dataset, (ii)–(iv) three sets of human
proteins contained within each of the human-bacteria networks, (v)
the set of human proteins found to interact with at least two
pathogens, and (vi) the set of human proteins found to interact
with all human pathogens (B. anthracis, F. tularensis, and Y. pestis). A
bias towards high-degree proteins in the last five distributions
would suggest that B. anthracis, F. tularensis, Y. pestis have evolved to
interact with higher degree proteins in the human PPI network.
Analysis of betweenness centrality in the human PPI
network. The degree of a protein captures only its local
connectivity. Betweenness centrality (BC) measures capture both
global and local features of a protein’s importance in a network
[39]. A protein with high betweenness centrality is characteristic of
a bottleneck in an interaction network (i.e., there are many paths
which pass through this protein) [40]. The betweenness centrality for a
protein v MV is defined as the fraction of shortest paths in G
between all protein pairs (u, w) that pass through the protein v.
Given u, v, w MV, let Suw denote the number of shortest paths
between proteins u and w. There may be multiple equally long
paths between u and w that are shorter than any other path
between u and w. Let Suw(v) denote the number of these that pass







To compute the betweenness centrality for each protein in G,w e
used the algorithm devised by Brandes [41]. This algorithm runs in
time proportional to the product of the number of nodes in G and
the number of edges in G. We plotted distributions for the same six
sets as in the degree analysis. Again, if the distribution for the last
five sets is biased toward higher values of centrality than the
distribution for the first set, we could hypothesize that B. anthracis, F.
tularensis, and Y. pestis have evolved to interact with proteins with
high betweenness centrality in the human PPI network.
Gene set enrichment analysis. We used Gene Set
Enrichment Analysis (GSEA) to determine if the human proteins
interacting with B. anthracis, F. tularensis, and/or Y. pestis have
significantly higher degree or betweenness centrality than
randomly picked proteins in G [16]. Let L be the ranked list of
the proteins in V, where we rank the proteins either by degree or
by betweenness centrality. Given L and a predefined set S of
proteins of interest (e.g., those interacting with B. anthracis), we used
GSEA to determine whether the proteins contained in S are
randomly distributed throughout L or concentrated at the top. In
the ranked list L, let li be the value (of degree or centrality) at index
i;1 #i#|L|. We abuse notation and say that an index i is an
element of S if the protein whose rank is i belongs to S. First, we
computed m=Si M Lli, the sum of all the values in L. Next, for each








j = [S, jƒi
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Thus, Phit(S, i) measures the weighted fraction of proteins with
index at most i that are in S and Pmiss(S, i) measures the fraction of
proteins with index at most i that are not in S. We handled
multiple ranks with identical values by computing Phit and Pmiss
only at the largest rank for each unique value in L. Finally, we




max Phit(S,i){Pmiss(S,i),0 ðÞ ðÞ
A large positive value of es(S, L) indicates that the proteins in S
have high degree or high betweenness centrality. Note that our
modification of the original definition of the enrichment score [33]
ensures that if S mainly contains proteins with low degree or
betweenness centrality, then the score will be close to 0, since
Phit(S, i)2Pmiss(S, i) will be negative for most indices. To compute p-
values for an observed enrichment scores, we generated a null
distribution of scores by repeatedly selecting |S| random nodes in
L and computing the enrichment score for each random subset of
nodes. We repeated this process 1,000,000 times and estimated the
p-value for s as the fraction of random sets whose enrichment score
is at least as large as s.
Identifying paralogous and orthologous protein
pairs. In preparation for computing conserved protein
interaction modules, we computed orthologous pairs of proteins
in every pair of pathogens. We used Inparanoid [28] with default
parameters to define orthologous pairs of proteins. The
Inparanoid algorithm outputs pairs of clusters. Each cluster in a
pair contains proteins from the same organism. The protein at the
center of a cluster has a weight of one and the other proteins in the
cluster have a weight between zero and one, depending on their
similarity to the protein at the center. In a given pair of clusters, for
every pair of proteins (one from each cluster), we use the products
of the weights of the two proteins as an estimate of the degree of
orthology of the protein pair. In addition, we used OrthoMCL
[29] with default parameters and a BLAST e-value cutoff of 10
210
to identify paralogous pairs of human proteins. We assigned a
weight of one to all paralogous pairs. For the sake of convenience,
we considered a human protein appearing in one human-
pathogen PPI network to be paralogous to a copy of the same
protein appearing in another human-pathogen network.
Conserved human-pathogen PPI modules. Given a pair
of human-pathogen PPI networks B1 and B2, let Z be the bipartite
graph whose edges are the orthologous and paralogous pairs of
proteins between B1 and B2, as computed above. We used a weight
of one for all edges (the PPIs) in B1 and B2. For edges in Z, we used
the weights defined in the previous sections. Let we denote the
weight of edges e in Z. Following the GrapHopper algorithm [34],
we defined a Conserved Protein Interaction Module (CPIM) to be a triple
(T1, T2, O) where T1 and T2 are connected subgraphs of B1 and
B2, respectively, and O#Z such that (a, b) MO if and only if a is a
node in B1 and b is a node in B2. Thus, O is the subgraph of Z
Human-Bacterial PPI Networks
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quality for a CPIM: interaction score and conservation score.
We defined the interaction score of a CPIM (T1, T2, O) to be simply
the total number of host-pathogen PPIs in B1 or in B2 and denoted
this score by q(T1, T2, O). Given T1 and T2, a small value of the
score indicates that we could connect the proteins in T1 and in T2
using a small number of PPIs. The conservation score of a CPIM
(T1, T2, O) measures the amount of evolutionary similarity (at the
amino acid level) between the human-pathogen interaction
networks T1 and T2. Let P1 (respectively, P2) be the sets of nodes
(both human and pathogen) in T1 (respectively, T2). We defined





i.e., the total weight of the orthologous or paralogous pairs of
nodes in the CPIM divided by the total number of nodes in the
CPIM. The larger this score, the more evolutionary conserved we
consider T1 and T2 to be, since there are fewer proteins without
orthologs or paralogs in the CPIM. Note that if we are given T1
and T2, we can maximize this score by making O the subgraph of
Z induced by P1 and P2.
The GraphHopper Algorithm. We used the GraphHopper
algorithm [34] to compute CPIMs. For the sake of completeness,
we describe the algorithm here. Given two human-pathogen PPI
networks B1 and B2, GraphHopper finds CPIMs by ‘‘hopping’’
from one network to another using orthology and paralogy
relationships. We did not provide PPIs between human proteins
as input to GraphHopper. GraphHopper attempts to find CPIMs
with high conservation and low interaction score. At a high level,
the algorithm starts with a connected basis CPIM that contains
four nodes and edges. Iteratively, the algorithm ‘‘hops’’ from one
PPI network to another. In each iteration, GraphHopper expands
the CPIM to increase the conservation score, while attempting to
keep the interaction score as low as possible. We now provide
details about the algorithm. Although the GraphHopper
algorithm has been described earlier [34], we include these
details here in order to make this work self-contained. Our inputs
are two human pathogen protein interaction networks B1=(V1,
E1)a n dB2=(V2, E2)a n das e tZ of orthologous or paralogous
protein pairs.
Computing basis CPIMs. We start by constructing a basis
set of CPIMs in which each CPIM (T1, T2, O) has the following
properties:
i. O contains two edges (a, a9) M Z and (b, b9) M Z;
ii. a and b are connected by at most one intermediate protein in
B1; and
iii. a9 and b9 are connected by an intermediate protein in B2.
Thus, each basis CPIM consists of two or four host-pathogen
PPIs (one or two each in T1 and in T2) and two orthology or
paralogy edges. The basis set consists of all such CPIMs.
Expanding a basis CPIM. GraphHopper processes each
CPIM in the basis set using the following iterative algorithm (see
Figure 5). Let (T1, T2, O) be a basis CPIM. In iteration k.1, we

















k21), i.e., the new CPIM







k21) is as small as possible,
i.e., the new CPIM has as few PPIs added to it as possible.
We keep either T1
k21 or T2
k21 fixed and ‘‘expand’’ the other




k21 is a subgraph of T2




k) using the following steps:
i. We identify a set P#V2 of nodes such that each node vMP is
not a node in T2
k21 and is connected by an edge in Z to at
least one node in T1
k.
ii. For each node v M P, we use breadth-first search to compute
the shortest path pv in B2 that connects v to T2
k21, i.e., for
each node u M T2
k21, we compute the shortest path between u
and v in B2, and set pv to be the shortest of these paths.
iii. We find the node v9 in P such that pv9 is the shortest among
all paths computed in the previous step.
iv. We set T2
k to be the union of T2
k21 and pv9.
v. We set O
k to be the union of O
k21 and the set of edges in Z
incident on v9and a node in T1
k.














Figure 5. GraphHopper extension of basis CPIM. An illustration of how GraphHopper expands a CPIM in iteration k. Each image shown two
host pathogen PPI networks, one on the left (blue proteins) and one of the right (red proteins). In these images, we do not distinguish between host
and pathogen proteins since GraphHopper treats these equally. Solid edges denote PPIs and dashed edges denote orthologs or paralogs. (A) A CPIM
at the end of iteration k21. (B) In iteration k, GraphHopper keeps the network in left side of the CPIM fixed and expands the network in the right side
of the CPIM. The two nodes marked by arrows belong to the set P. The node v9 is the lower of these two nodes. GraphHopper adds the thick red
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k fixed. Otherwise, we stop expanding this
CPIM and proceed to the next basis CPIM.




k21) after setting T1
k=T1
k21, we first identify the
set P of nodes in B2 that do not belong to T2
k21 but are orthologs
of nodes in T1
k. Each node in P is a candidate that we can add to
T2
k21 in order to construct T2
k. However, such a node vMP may
not be adjacent to any node in T2







k21) as small as possible, we
would like to connect v to T2
k21 using the fewest edges in B2.A
natural candidate for this set of edges is the shortest path pv
connecting v to T2
k21, where this minimum is taken over the set of
shortest paths connecting v to each node in T2
k21. Therefore, for
each node v in P, we compute the shortest path pv by which we can
connect pv to T2
k21 using only edges in B2. We add that path pv to
T2
k21that is shortest among all the paths computed i.e., v9=arg
minv M P |pv|. After computing T2
k, we set O
k to be the subgraph of
Z induced by the nodes in T1
k and T2
k by adding the edges in Z
that are incident on v9and any node in T1
k; by construction, no
node in pv9 other than v9 is connected by an edge in Z to a node in
T1




we continue expanding (T1
k, T2
k, O




k21). Otherwise, we stop the










k) implicitly plays a role in the expansion: by choosing
to add the shortest pv to T2








Assessing the statistical significance of a CPIM. We
computed the statistical significance of a CPIM using standard
methods [33]. We computed two random PPI networks with the
same degree distribution as B1 and B2 and a random network
connecting nodes in B1 to nodes in B2 with the same degree
distribution as Z. We computed a histogram of the conservation
scores of all CPIMs that GraphHopper finds in these networks. We
amalgamated histograms over 10,000 random inputs and estimated
the p-value of a CPIM (T1, T2, O) as the fraction of CPIMs in
random networks whose conservation score is at least as large as
w(T1, T2, O). We retained CPIMs that have p-value at most 0.05.
CPIM Functional Enrichment. For each CPIM we compute
enriched Gene Ontology (GO) [20] functions for five sets of
proteins: the set of human proteins interacting with the first
pathogen, the set of human proteins interacting with the second
pathogen, all human proteins in the CPIM, and each of the two sets
of pathogen proteins in the CPIM. For a set of proteins S, e.g., those
interacting with the first pathogen, we compute enriched functions
as follows. For every function f in GO, let sf be the number of
proteins in H annotated with f. Let uf be the number of proteins in
theuniverse U annotated with f.Astheuniverseforhumanproteins,
we used the set of all human proteins we have identified in the
human activation library (including experiments not described
here). For pathogen proteins, we used the set of pathogen proteins
found to interact with at least one human protein as the universe.














We retained functions only for which pf#0.05 after accounting for
multiple hypothesis testing using the method of Benjamini and
Hochberg [42]. Since functions in GO are specified at multiple
levels of detail, the set of enriched function pairs may contain closely
related pairs of functions. We used the following criteria to collapse
the enriched functions to the most specific and the most enriched.
From the set of all enriched functions, we removed a function f if
there is another function g such that
i. pg,pf i.e., g is more statistically significant than f, and
ii. g is either an ancestor or a descendant of f.
Thus, we retained a function g precisely when g is more
significant than all its ancestors and all its descendants in GO.
Merging CPIMs. The steps described above convert each
basis CPIM into an expanded CPIM with high conservation and
low interaction score. However, the expanded CPIMs may have
considerable overlap. We modified the procedure used by Sharan
et al. [33] to merge CPIMs. For each CPIM C, we computed all the
biological functions it is enriched in and record the function fC that
is most enriched (has smallest p-value) in C. Let F be the set of all
such most-enriched functions. Finally, for each function lMF,w e
computed a CPIM Cl as the union of all CPIMs C for which l=fC,
i.e., Cl=<l=Cl C. We report results for these CPIMs. Note that
this method (i) does not require us to provide a cutoff on the
overlap of two CPIMs that should be merged, (ii) allows merged
CPIMs to share both proteins and interactions, and (iii) may yield
disconnected CPIMs. For each such CPIM, we recomputed the
most enriched function. We added other proteins annotated with
the function to the CPIM, as long as they participate in a host-
pathogen PPI and the pathogen protein is a known virulence
factor. Note that the images in the main text only display
interactions involving virulence factors and uncharacterized
pathogen proteins, for the sake of clarity.
Datasets used. We gathered 78,804 PPIs between human
proteins from seven databases: the Biomolecular Interaction Network
Database [7], the Database of Interacting Proteins [12], the Human
Protein Reference Database [11], IntAct [9], the Molecular
INTeraction database [13], the Munich Information Center for
Protein Sequences [8], and Reactome [10]. For some analyses, we
considered a human PPI network assembled from unbiased high-
throughput experiments [43,44,45] and a network constructed from
only manually curated human PPIs [10,11]. These networks
contained 13,172 and 64,427 interactions respectively. We also
obtained functional annotations from the Gene Ontology (GO) [20].
We gathered information on virulence factors from MVirDB [46].
These data were downloaded in February 2008.
Conclusions
In summary, we have provided the first large-scale PPI map for
three respiratory bacterial pathogens and their human host.
Systematic screening of human-pathogen PPIs also allows us to
uncover novel interactions of relevance for understanding patho-
genesis, host response, all of which can be applied the development
of novel vaccines and immunotherapeutics. In line with recent
trends in drug discovery favoring polypharmacology (i.e., drugs
acting upon multiple targets), over single target drugs [47], there is a
renewed emphasis for developing broadly protective immunother-
apeutics against infectious diseases. Accordingly, discovering novel
putative targets through the comprehensive lens of protein networks
may provide valuable novel insights for developing novel drugs and
vaccines against respiratory pathogens.
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